Pharmacy Daily | Clinical trial compliance patent

US health technology firm ERT has been granted two patents on Clinical Trial Subject Compliance. The company said the patents cover the “tracking and enhancement of participant compliance with a research protocol,” and can be used to provide evaluability data related to participant performance in a trial. Compliance is tracked using two ERT electronic diary products: DIARYpro (for remote patient data collection) and SITEpro (for sitebased data collection). ERT has now launched a tiered licensing program to allow other industry suppliers to incorporate the functionality in their products. DIARYpro and SITEpro utilise the patented methods “and have been repeatedly proven to capture important clinical outcome assessment data at the point of the participant’s experience, yielding a more accurate measurement of treatment effect” - www.ERT.com.

---

The above article was sent to subscribers in Pharmacy Daily's issue from 18 Jul 12
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 18 Jul 12